Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells

Yamada, Nami; Tsujimura, Nonoka; Kumazaki, Minami; Shinohara, Haruka; Taniguchi, Kohei; Nakagawa, Yoshihito; Naoe, Tomoki; Akao, Yukihiro

doi:10.1016/j.bbagrm.2014.09.002

Cited by 139 publications

(128 citation statements)

References 32 publications

Supporting

Mentioning

123

Contrasting

Unclassified

Order By: Relevance

“…MVs released from human renal cancer stem cells triggered angiogenesis and formed a pro-metastatic niche in lungs [18]. Recently, it has been reported that miR-1245 in colorectal cancer cell-derived MVs promoted angiogenesis in vitro [26]. In this study, we found that the tumor-derived miR-494 was delivered en route MVs into ECs to promote angiogenesis.…”

Section: Discussionmentioning

confidence: 79%

Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

et al. 2015

View full text Add to dashboard Cite

Angiogenesis, a crucial step in tumor growth and metastasis, is regulated by various pro- or anti-angiogenic factors. Recently, microRNAs have been shown to modulate angiogenic processes by modulating the expression of critical angiogenic factors. However, roles of tumor-derived microRNAs in regulating tumor vascularization remain to be elucidated. In this study, we found that delivery of miR-494 into human vascular endothelial cells (ECs) enhanced the EC migration and promoted angiogenesis. The angiogenic effect of miR-494 was mediated by the targeting of PTEN and the subsequent activation of Akt/eNOS pathway. Importantly, co-culture experiments demonstrated that a lung cancer cell line, A549, secreted and delivered miR-494 into ECs via a microvesicle-mediated route. In addition, we found that the expression of miR-494 was induced in the tumor cells in response to hypoxia, likely via a HIF-1α-mediated mechanism. Furthermore, a specific miR-494 antagomiR effectively inhibited angiogenesis and attenuated the growth of tumor xenografts in nude mice. Taken together, these results demonstrated that miR-494 is a novel tumor-derived paracrine signal to promote angiogenesis and tumor growth under hypoxic condition.

show abstract

Section: Discussionmentioning

confidence: 79%

Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

et al. 2015

View full text Add to dashboard Cite

show abstract

“…26,27 Several studies have indicated that the overexpression of R-SMADs, especially SMAD-1 and SMAD-8, may be a valuable prognostic factor; however, further studies must be performed. 28,29 This study represents the first investigation of the expression of SMAD proteins of all groups in CLL cells. In addition, they are evaluated as novel prognostic markers for disease outcome.…”

Section: Introductionmentioning

confidence: 99%

The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia

et al. 2017

View full text Add to dashboard Cite

The SMAD proteins are responsible for transducing signals from activated transforming growth factor-beta. This is the first study assessing the expression of SMAD-1/8, SMAD-2/3, SMAD-4, and SMAD-7 in chronic lymphocytic leukemia cells with regard to their clinical significance and potential prognostic value. Overexpression of SMAD-1/8 was observed in 160 chronic lymphocytic leukemia patients compared to 42 healthy volunteers (p = 0.023) and was associated with a more progressive course of the disease (p = 0.016). Moreover, the high expression of SMAD-1/8 correlated with other, well-established prognostic factors, including clinical stage (p = 0.010) and lymphocyte doubling time (p = 0.021). The expression of SMAD-4 was lower in chronic lymphocytic leukemia patients compared with the control group (p = 0.003). Importantly, lower SMAD-4 levels correlated with longer progression-free survival (p = 0.009), progressive course of the disease (p = 0.002), advanced clinical stage (p = 0.0004), elevated beta-2-microglobulin and lactate dehydrogenase levels (p < 0.05), shorter lymphocyte doubling time (p = 0.009), and CD38 antigen expression (p = 0.039). In addition, lower SMAD-4 expression correlated with lower apoptotic index (p = 0.0007) and lower expression of receptors for vascular endothelial growth factors VEGFR-1 and VEGFR-2. A significant association was found between the low expression of inhibitory protein SMAD-7 and both zeta-chain-associated protein kinase 70-negative cells (p = 0.04) and lower apoptotic index (p = 0.004). No differences were observed in SMAD-2/3 expression. In conclusion, our results demonstrate a significant correlation between greater SMAD-1/8 and lower SMAD-4 expression in chronic lymphocytic leukemia cells, as well as more progressive outcome and poor prognosis. These data provide supporting evidence that the expression of SMAD proteins plays an important role in disease development and may be considered as a novel, biologic prognostic factor in this disease.

show abstract

“…The tumor vascular uptake of Cy7-TCP-1 might represent a specific biomarker expressed on endothelial cell phenotypes promoted by or derived from the colon cancer cells. Tumor cells can release angiogenic factors into their surrounding environment to promote new vessel growth [41]. Stem-like tumor cells can directly transdifferentiate into endothelial cells in vivo [23].…”

Section: Discussionmentioning

confidence: 99%

Characterization of TCP-1 probes for molecular imaging of colon cancer

Liu

Gray

Barber

et al. 2016

Journal of Controlled Release

View full text Add to dashboard Cite

Molecular probes capable of detecting colorectal cancer (CRC) are needed for early CRC diagnosis. The objective of this study was to characterize c[CTPSPFSHC]OH (TCP-1), a small peptide derived from phage display selection, for targeting human CRC xenografts using technetium-99m (99mTc)-labeled TCP-1 and fluorescent cyanine-7 (Cy7)-labeled form of the peptide (Cy7-TCP-1). 99mTc-TCP-1 was generated by modifying TCP-1 with succinimidyl-6-hydrazino-nicotinamide (S-HYNIC) followed by radiolabeling. In vitro saturation binding experiments were performed for 99mTc-TCP-1 in human HCT116 colon cancer cells. SCID mice with human HCT116 cancer xenografts were imaged with 99mTc-TCP-1 or control peptide using a small-animal SPECT imager: Group I (n=5) received no blockade; Group II (n=5) received a blocking dose of non-radiolabeled TCP-1. Group III (n=5) were imaged with 99mTc-labeled control peptide (inactive peptide). SCID mice with human PC3 prostate cancer xenografts (Group IV, n=5) were also imaged with 99mTc-TCP-1. Eight additional SCID mice bearing HCT116 xenografts in dorsal skinfold window chambers (DSWC) were imaged by direct positron imaging of 18F-fluorodeoxyglucose (18F-FDG) and fluorescence microscopy of Cy7-TCP-1. In vitro 99mTc-HYNIC-TCP-1 binding assays on HCT 116 cells indicated a mean Kd of 3.04 ± 0.52 nM. In cancer xenografts, 99mTc-TCP-1 radioactivity (%ID/g) was 1.01±0.15 in the absence of blockade and was reduced to 0.26±0.04 (P < 0.01) with blockade. No radioactive uptake was observed in the PC3 tumors with 99mTc-TCP-1 or HCT116 tumors with inactive peptide. Cy7-TCP-1 activity localized not only in metabolically active tumors, as defined by 18F-FDG imaging, but also in peritumoral microvasculature. In conclusion, TCP-1 probes may have a distinct targeting mechanism with high selectivity for CRC and tumor-associated vasculature. Molecular imaging with TCP-1 probes appears promising to detect malignant colorectal lesions.

show abstract

Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells

Cited by 139 publications

References 32 publications

Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

The distribution and potential prognostic value of SMAD protein expression in chronic lymphocytic leukemia

Characterization of TCP-1 probes for molecular imaging of colon cancer

Contact Info

Product

Resources

About